Source Data-AdipoR1/2 Dual Agonist and EDP Inhibitor Combination Therapy for NAFLD
收藏官方服务：
资源简介：
AdipoR1/2 Dual Agonist and EDP Inhibitor Combination Therapy for NAFLD
应用场景：
创建时间：
2020-09-05
相关数据集
DataSheet1_Polygoni Multiflori Radix Praeparata Ethanol Extract Exerts a Protective Effect Against High-Fat Diet Induced Non-Alcoholic Fatty Liver Disease in Mice by Remodeling Intestinal Microbial Structure and Maintaining Metabolic Homeostasis of Bile Acids.zip
In the prescription of Traditional Chinese Medicine for lipid metabolism, Polygoni Multiflori Radix Preparata (ZhiHeShouWu, RPMP) was widely used. In recent years, RPMP ethanol extract has been report
NIAID Data Ecosystem30
Efficacy of antihistamines in combination with topical corticosteroid and superficial cryotherapy for treatment of alopecia areata: A retrospective cohort study
Supplementary Table 1. Previously published clinical studies of antihistamine for treatment of alopecia areata
NIAID Data Ecosystem20
Placebo-controlled, randomized clinical trial with repeated liver biopsies: Long-term resveratrol treatment has no clear therapeutic benefit in non-alcoholic fatty liver disease
Resveratrol treatment has shown beneficial effects on experimental models of non-alcoholic liver disease (NAFLD). In this pilot-size, clinical trial we teated the therapeutic potential in NAFLD patien
NIAID Data Ecosystem20
Available datapackage for study 'A Phase III, Double-blind, Placebo-controlled, Randomized Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Patients With Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer'
This study evaluated the efficacy and safety of ipatasertib in combination with atezolizumab and paclitaxel in locally advanced or metastatic Triple-Negative Breast Cancer (TNBC) previously untreated
DataCite Commons2025-02-24 更新20
Supplementary Material for: Microbial Intervention as a Novel Target in Treatment of Non-Alcoholic Fatty Liver Disease Progression
Background/Aims: Emerging evidence suggests a close link between gut microbiota and non-alcoholic fatty liver disease (NAFLD). In this study, we aimed to investigate the association between gut microb
Figshare2018-12-06 更新20
